...
首页> 外文期刊>Biomaterials >Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression
【24h】

Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression

机译:验证含有细胞瘤病毒启动子的人工线粒体报告DNA载体用于线粒体转基因表达的用途

获取原文
获取原文并翻译 | 示例
           

摘要

Mitochondria have their own gene expression system that is independent of the nuclear system, and control cellular functions in cooperation with the nucleus. While a number of useful technologies for achieving nuclear transgene expression have been reported, only a few have focused on mitochondria. In this study, we validated the utility of an artificial mitochondrial DNA vector with a virus promoter on mitochondrial transgene expression. We designed and constructed pCMV-mtLuc (CGG) that contains a CMV promotor derived from Cytomegalovirus and an artificial mitochondrial genome with a NanoLuc (Nluc) luciferase gene that records adjustments to the mitochondrial codon system. Nluc luciferase activity measurements showed that the pCMV-mtLuc (CGG) efficiently produced the Nluc luciferase protein in human HeLa cells. Moreover, we optimized the mitochondrial transfection of pCMV-mtLuc (CGG) using a MITO-Porter system, a liposome-based carrier for mitochondrial delivery via membrane fusion. As a result, we found that transfection of pCMV-mtLuc (CGG) by MITO-Porter modified with the KALA peptide (cationic amphipathic cell-penetrating peptide) showed a high mitochondrial transgene expression. The developed mitochondrial transgene expression system represents a potentially useful tool for the fields of nanoscience and nanotechnology for controlling the intracellular microenvironment via the regulation of mitochondrial function and promises to open additional innovative research fields of study. (C) 2017 Elsevier Ltd. All rights reserved.
机译:线粒体有自己的基因表达系统,与核系统无关,并控制与核合作的蜂窝功能。据报道,虽然已经报道了多种用于实现核转基因表达的有用技术,但只有少数集中于线粒体。在这项研究中,我们通过对线粒体转基因表达的病毒启动子进行了验证了人造线粒体DNA载体的效用。我们设计和构建了PCMV-MTLUC(CGG),其含有衍生自塞细胞病毒的CMV促进剂和具有纳米卢克(Nluc)荧光素酶基因的人造线粒体基因组,其记录对线粒体密码子系统的调整。 Nluc荧光素酶活性测量结果表明,PCMV-MTLUC(CGG)有效地生产人Hela细胞中的Nluc荧光素酶蛋白。此外,我们利用Mito-Porter系统优化了PCMV-MTLUC(CGG)的线粒体转染,该脂质体基载体通过膜融合进行线粒体输送。结果,我们发现用kala肽(阳离子两亲渗透肽)改性的mito-porter转染pcmv-mtluc(cgg),显示出高线粒体转基因表达。开发的线粒体转基因表达系统代表了通过对线粒体功能的调节控制细胞内微环境的纳米科学和纳米技术领域的潜在有用的工具,并承诺开放额外的创新研究研究。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号